Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19 - Painter, G R; Natchus, M G; Cohen, O; Holman, W; Painter, W P (Curr Opin Virol, 2021)